Literature DB >> 14685761

Predictive medicine in urology.

Bernd J Schmitz-Dräger, Nuria Malats, Pierfrancesco Bassi.   

Abstract

Facing the limitations of financial resources available for health services, the necessity of evaluating new strategies in health management becomes evident. Experience from non-urological diseases suggests that prevention not only can reduce the number of incidences but also can be cost-effective. Predictive medicine or modern risk assessment could be a powerful tool to determine a given individual's risk for eventually developing the disease. A significant reduction in disease-related mortality as well as a reduction in costs can be expected if prevention and screening are focused on individuals at risk.

Mesh:

Year:  2003        PMID: 14685761     DOI: 10.1007/s00345-003-0380-x

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  14 in total

Review 1.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review.

Authors:  Maurice P A Zeegers; Eliane Kellen; Frank Buntinx; Piet A van den Brandt
Journal:  World J Urol       Date:  2003-12-17       Impact factor: 4.226

Review 2.  Prevention of heart failure.

Authors:  David W Baker
Journal:  J Card Fail       Date:  2002-10       Impact factor: 5.712

Review 3.  Epidemiologic aspects of cancer prevention in Germany.

Authors:  N Becker
Journal:  J Cancer Res Clin Oncol       Date:  2001-01       Impact factor: 4.553

4.  Heart failure: how can we prevent the epidemic?

Authors:  Duncan J Campbell
Journal:  Med J Aust       Date:  2003-10-20       Impact factor: 7.738

Review 5.  Lifestyle issues and genitourinary tumours.

Authors:  Frank Sommer; Theo Klotz; Bernd J Schmitz-Dräger
Journal:  World J Urol       Date:  2003-12-12       Impact factor: 4.226

Review 6.  How cost-effective are new preventive strategies for cardiovascular disease?

Authors:  Jeffrey L Probstfield
Journal:  Am J Cardiol       Date:  2003-05-22       Impact factor: 2.778

7.  Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity.

Authors:  Andrew J Coldman; Norman Phillips; Thomas A Pickles
Journal:  CMAJ       Date:  2003-01-07       Impact factor: 8.262

8.  Screening for prostate cancer in high risk populations.

Authors:  William J Catalona; Jo Ann V Antenor; Kimberly A Roehl; Judd W Moul
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

Review 9.  Occupational exposure and urological cancer.

Authors:  Klaus Golka; Andreas Wiese; Giorgio Assennato; Hermann M Bolt
Journal:  World J Urol       Date:  2003-11-26       Impact factor: 4.226

Review 10.  Genetic polymorphisms and prostate cancer risk.

Authors:  Andrea Gsur; Elisabeth Feik; Stephan Madersbacher
Journal:  World J Urol       Date:  2003-11-26       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.